AHCC06 Phase III Multi-Centre Open-Label Randomized Controlled Trial of Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (NCT01135056)
Final Analysis Result Presentation at 2017 ASCO Annual Meeting
Chicago, 4 June 2017
The result of the final analysis of the AHCC06 will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on 4 June 2017 in Chicago. AHCC06 Principal Investigator, Prof Pierce Chow will be presenting the result for the 1st time. The ASCO Annual Meeting is one of the largest educational and scientific events in the oncology community.